Pandemic influenza vaccine development: time is of the essence.
Cox
Rebecca J
RJ
Brokstad
Karl A
KA
Haaheim
Lars R
LR
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D004196:Disease Outbreaks / Q000517:prevention & control*; D015195:Drug Design; D014943:Global Health; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission / Q000821:virology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines